AGP Executive Report
Last update: 10 hours agoNew Drug Results: Cue Biopharma reported positive Phase 2 topline results for CUE-221 (UB-221) in China for chronic spontaneous urticaria, meeting primary and key secondary endpoints with a favorable safety profile and a differentiated efficacy pattern versus omalizumab. Child Health Watch: A Kiang Wu Hospital study flags rising childhood obesity in Macau (7.5% obese, 11% overweight), warning of longer-term cardiovascular, respiratory, concentration and sleep impacts. Screen Time & Mental Health: Macau-focused research on healthcare students links problematic internet use to depression, with insomnia playing a mediating role—suggesting sleep support could help. Community Wellbeing & Tourism Work: A Macau tourism piece argues employee wellbeing matters behind visitor numbers, tying staff health to service quality and retention. Food & Mood for Better Choices: Macau University of Science and Technology research suggests calm, low-arousal music can nudge healthier food choices in canteens and simulated settings. Local Care Capacity: Macao Union Hospital marked its second anniversary, highlighting expanded expert support and focus areas from pancreatic to rare diseases. Cross-border Health Access: A Hengqin survey found high satisfaction among Macau families with healthcare and other services, with consumer convenience nearing 90%. Public Health Alert (HK): Hong Kong is investigating a locally acquired chikungunya case and urges mosquito bite prevention and breeding-site control.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
